27795903
Results 1 to 1 of 1
Selection :
Three-arm randomised controlled phase 2 study comparing pemetrexed and erlotinib to either pemetrexed or erlotinib alone as second-line treatment for never-smokers with non-squamous non-small cell lung cancerDAE HO LEE; JUNG SHIN LEE; XIN WANG et al.European journal of cancer (1990). 2013, Vol 49, Num 15, pp 3111-3121, issn 0959-8049, 11 p.Article
